熱門資訊> 正文
MangoRx收到澳大利亚专利申请受理通知
2024-06-06 21:47
- Mangoceuticals (NASDAQ:MGRX) on Thursday announced that it received a notice of acceptance from the Australian patent authority.
- The notice of acceptance covers the proprietary formulation and application methods designed to combat a wide range of infections, including common colds, respiratory diseases, and orally transmitted infections such as human papillomavirus, the company added.
- Acceptance of the application will officially be published in the Australian Official Journal of Patents on June 6, 2024.
- Source: Press Release
More on Mangoceuticals
- Mangoceuticals stock rallies on Japanese patent allowance
- Microcap Mangoceuticals doubles on plan to sell cheap oral GLP-1 weight loss meds
- Financial information for Mangoceuticals
推薦文章
風險及免責提示：以上內容僅代表作者的個人立場和觀點，不代表華盛的任何立場，華盛亦無法證實上述內容的真實性、準確性和原創性。投資者在做出任何投資決定前，應結合自身情況，考慮投資產品的風險。必要時，請諮詢專業投資顧問的意見。華盛不提供任何投資建議，對此亦不做任何承諾和保證。
